Amae Health Announces $25 Million Series B to Advance Toward a Cure for Severe Mental Illness

Amae Health notes the Series B round, led by Altos Ventures with participation from existing investors, will accelerate Amae’s AI-powered precision-care platform and partnerships with leading academic medical centers—marking a decisive step toward curative psychiatry